Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal Study of Osteoporosis in Women (GLOW), we analyzed ri...

Full description

Bibliographic Details
Main Authors: Díez-Pérez, A, Adachi, J, Adami, S, Anderson, F, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Gehlbach, S, Greenspan, S, Hooven, F, LaCroix, A, Nieves, J, Netelenbos, J, Pfeilschifter, J, Rossini, M, Roux, C, Saag, K, Silverman, S, Siris, E, Wyman, A, Rushton-Smith, S, Watts, N
Format: Journal article
Language:English
Published: 2014

Similar Items